Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

UK must be wary of South Africa variant as third wave hits Europe, Neil Ferguson says

‘That is the variant we really do want to keep out of the UK,’ senior scientific adviser says

Samuel Osborne
Friday 19 March 2021 09:51 GMT
Comments
Th delay in vaccine supply in the UK will not have a big effect on the vaccine rollout, Professor Neil Ferguson says
Th delay in vaccine supply in the UK will not have a big effect on the vaccine rollout, Professor Neil Ferguson says (AP/Kirsty Wigglesworth)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

The UK must be wary of the South African coronavirus variant as some European countries are hit by a third wave of Covid-19, a senior scientific adviser has warned.

Professor Neil Ferguson, from Imperial College London, said a group of European countries are seeing increasing levels of cases, albeit driven by the Kent variant.

"Perhaps more concern for the UK though is that some countries are notably seeing a significant fraction, 5-10 per cent of cases, of the South African variant," he told BBC Radio 4's Today programme.

"When infection levels go up in France, 30,000 cases a day, that implies there's at least 1,500-2,000 cases a day of the South African variant.

"That is the variant we really do want to keep out of the UK."

A case of the South African variant was identified in the Sandwell area of the West Midlands earlier this week, with surge testing employed in the area to help prevent its spread.

Read more:

Prof Ferguson also said important decisions needed to be made on how the UK can trade with France as the country faces a third lockdown.

"I think there are important decisions coming up, and it's always a balancing act.

"How much we relax the current ban on international travel except for essential services.

"As a lot of essential travel between ourselves and France for business, commerce and trade, how can we reduce the risks associated with that travel.

"Those are policy decisions, I'm just raising the issue that we are doing so well with the vaccination campaign, we are driving down deaths at a faster rate than I ever thought was possible and that will allow us to open up."

Asked whether he thought France should be added to the red list,he replied: "I don't think that's necessarily a practical issue given the amount of trade."

Paris will enter new lockdown measures on Friday, with residents of 16 departments allowed to leave home only under specific circumstances.

Only essential shops will remain open, inter-regional travel is banned, while anyone travelling more than 10km from home or in the evenings will need to fill out a form explaining the purpose of their trip.

It comes after Italy entered its third lockdown earlier this week.

Prof Ferguson also said the delay in vaccine supply in the UK will not have a big effect on the vaccine rollout.

Earlier this week, NHS England warned the UK faces a month-long “significant reduction” in its weekly vaccine supply from the end of March.

The expected reduction in supply is partly due to a delay in the delivery of five million Oxford/AstraZeneca doses from India.

The shipment, produced by the Serum Institute of India, has been held up by four weeks.

Prof Ferguson described the delay as "slightly disappointing", but added: "I don't think the delay will have an enormous effect.

"We'll still have enough vaccine to largely continue with the programme."

He said the South African variant remained the bigger concern, adding: "Overall, I'm optimistic with this one caveat that we do need to keep these variants of concern at bay.

"Until we can update the vaccine, rolled out the vaccine and really hopefully the whole adult population which will be this summer, at that point we'll be in a much safer position."

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in